Verition Fund Management’s Boston Scientific BSX Stock Holding History

Verition Fund Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,600	Closed	-$1.3M	–	2403
2025 Q4	$1.3M	Sell	13,600 -44,900	-77%	-$4.4M	0.01%	1954
2025 Q3	$5.71M	Buy	58,500 +12,500	+27%	+$1.29M	0.02%	1008
2025 Q2	$4.94M	Buy	46,000 +11,800	+35%	+$1.19M	0.02%	1129
2025 Q1	$3.45M	Sell	34,200 -5,300	-13%	-$534K	0.02%	1151
2024 Q4	$3.53M	Sell	39,500 -400	-1%	-$35.2K	0.01%	1152
2024 Q3	$3.34M	Hold	39,900	–	–	0.02%	1117
2024 Q2	$3.07M	Buy	39,900 +5,400	+16%	+$395K	0.02%	1029
2024 Q1	$2.36M	Buy	+34,500	New	+$2.22M	0.02%	1116
2022 Q4	–	Sell	-14,000	Closed	-$542K	–	2189
2022 Q3	$542K	Buy	+14,000	New	+$562K	0.01%	1842
2022 Q2	–	Sell	-38,200	Closed	-$1.69M	–	2398
2022 Q1	$1.69M	Buy	38,200 +21,000	+122%	+$910K	0.02%	1088
2021 Q4	$731K	Buy	+17,200	New	+$723K	0.01%	1492

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Verition Fund Management's BSX Position: Q1 2026 in Review

Verition Fund Management increased its Boston Scientific (BSX) stake by 99% in Q1 2026, buying an estimated $3.79M and bringing the position to 95,375 shares worth $5.98M. The position accounts for 0.04% of the portfolio, ranked #506.

Verition Fund Management first reported a position in BSX in Q3 2013 and has held it in 35 quarters since. The position peaked at $33.8M in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Verition Fund Management held 95,375 shares of Boston Scientific worth $5.98M as of Q1 2026.
Verition Fund Management bought 47,438 Boston Scientific shares in Q1 2026, an estimated $3.79M.
Boston Scientific made up 0.04% of Verition Fund Management's portfolio in Q1 2026, its #506 holding.
Verition Fund Management first reported a position in Boston Scientific in Q3 2013 and has held it in 35 quarters since.
Verition Fund Management's Boston Scientific position peaked at $33.8M in Q1 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.